Young Scientist Communication Team

Ilaria received her MSc in Pharmaceutical chemistry and Technology from the University of Turin in 2016. During her MSc, she spent six months in the laboratory of Prof. Fattal at the Institut Galien Paris-Sud. She obtained her PhD in Pharmaceutical and Biomolecular Sciences in 2022 from the University of Turin and Université Claude Bernard Lyon 1 by developing biocompatible nanosystems for innovative applications of small therapeutic molecules.

Ilaria is currently a post-doc at the University of Turin. Her research focuses on the formulation of liposomes decorated with hyaluronic acid for inhalation treatment.

Silvia obtained her M.S. Degree in Pharmacy and her PhD in Chemical and Pharmaceutical Science from the University of Pavia. She was a Research Assistant at Nanomedicine/EUNCL Laboratory Trinity Translational Medicine Institute (TTMI) / Department of Clinical Medicine (Supervisor: Prof. Adriele Prina-Mello), and a Visiting PhD student at Harvard - John A. Paulson –School of Engineering and Applied Science, Cambridge, USA (Supervisor: Prof. Kevin Kit Parker).

Silvia is currently a Post-doc at the IRCCS Fondazione Policlinico San Matteo, Pavia. Her research focuses on design, development and characterization of drug delivery systems and engineered scaffolds using Electrospinning, 3D-Bioprinting and High Efficiency Vibrational Technology for regenerative medicine purposes. Currently she is involved in a project aimed at developing a tubular cellularized scaffold for esophageal regeneration: from manufacturing to preclinical in vivo evaluation.

Ilaria graduated in Medicinal Chemistry in 2018 at the University of Modena, after completing her thesis at the University of Ulm, Germany, at the Department of Anatomy and Cell Biology. She completed her PhD in 2023, receiving the double title from both the universities of Modena and Angers, France, where she conducted part of her research in the field of Nanomedicine. Her research is currently focused on the optimization and validation of polymeric, lipidic, and hybrid nanoparticles for the delivery of genetic material (DNA, mRNA, and siRNA) and therapeutic proteins in the field of ocular and metabolic diseases. She is also involved in other research projects regarding the use of nanoparticles for neurodegenerative diseases, brain cancer, and enzyme replacement therapy.

Cristiano completed his Master`s degree in Pharmaceutical Chemistry and Technology in 2021 at the University of Padua (Italy), discussing a thesis focused on the synthesis of polycationic bioconjugates for oligonucleotide delivery carried under the supervision of Prof. Caliceti. He received his PhD in Pharmaceutical Sciences from University of Padua in 2025. His research focused on developing drug delivery systems of different scale (from nanoscale to macroscale) for different purposes: biodegradable polymeric implants (microMESH) for the local and sustained release of drugs and nanomedicines against glioblastoma, lipid nanoparticles (LNPs) for gene delivery, and nanomedicines to assess the predictive ability of AI-based tools. During his doctorate, he joined the lab of Nanotechnology for Precision Medicine at the Italian Institute of Technology (IIT) in Genova, under the supervision of Prof. Decuzzi, and the labs of Prof. Hutter and Prof. McNeil at the Universitatsspital and University of Basel (Switzerland).

Currently, he is a Post-doctoral Researcher at the Ludwig Boltzmann Institute (LBI) – NVPM Lab directed by Prof. Meisner-Kober.

Antonietta obtained her Master’s degree, cum laude, in Medical and Pharmaceutical Biotechnology, at University of Pavia in 2019. Afterwards, she spent 6 months abroad, with Erasmus Traineeship post-graduation project, at I3Bs - Research Institute on Biomaterials, Biodegradables and Biomimetics of University of Minho, Braga (Portugal). Antonietta obtained her PhD in Biomolecular Science and Biotechnology in 2023 at University School for Advanced Studies (IUSS) Pavia developing versatile polymeric nanoplatforms for drug delivery. During her PhD, she joined as Erasmus Traineeships student, the research group of Prof. Olivia Merkel (Ludwig-Maximilians-Universität München, Munich (Germany)) working on polymeric nanoparticles for nucleic acid and protein delivery.

Currently, she is a Postdoctoral Researcher fellow at the Italian Institute of Technology in Genoa where she works on nanotechnology and precision medicine studying micrometric and nanometric systems, composed of different materials, for the delivery of several drugs. Antonietta is interested in nucleic acid delivery and genome editing.

Marco graduated in Pharmacy at University of Calabria in 2018. He is currently a PhD student in Life Science and Technology at University of Calabria under the supervision of Prof. Francesco Puoci. During his PhD, he was a visiting student for 16 months in the laboratory of Prof. Börje Sellergren at the University of Malmö (Malmö, Sweden). 

His research focuses on the synthesis and characterization of polymeric functional materials for application in pharmaceutical field. In particular, he is currently working on the development of synthetic antibodies using Molecular Imprinting Technology, from bench formulations to clinical application and large-scale production, for the selective recognition of biomarkers and controlled release of anticancer drugs.

Mattia received his PhD in Pharmaceutical Sciences in 2021 from the University of Urbino Carlo Bo developing 3D printed pharmaceutical solutions. During the PhD period, he joined the group of Prof. Helder Santos at the University of Helsinki working on nanomedicine formulation and microfluidic manufacturing.

Currently, he is a postdoctoral researcher at the University of Urbino Carlo Bo. His research is focused on the application of 3D printing technologies in the pharmaceutical field spacing from the direct production of medicines and medical devices, to analytical, and manufacturing devices. Through 3D printing, he develop microfluidic devices for the manufacturing of innovative nanomedicines.

Mariella graduated in Pharmacy at University of Pavia in 2020 presenting a Master’s thesis on the antibacterial activity of antibiotic functionalized glasses, under the supervision of Prof. Pietro Grisoli. In 2013 and in 2012 she had the opportunity of internships, respectively at the Department of Biotechnology of the University of Insubria in Varese (Italy) and in a Q&C Laboratory at Lanxess GmbH in Krefeld-Uerdingen (Germany). In 2022 she spent 5 months at Trinity College Dublin (Ireland), working in the LBCAM research group headed by Prof. Adriele Prina-Mello. 

Currently, Mariella is concluding her PhD in Chemical-Pharmaceutical Sciences and Industrial Innovation at University of Pavia, under the supervision of Prof. Bice Conti and Prof. Ida Genta, working on the development of vascular grafts manufactured with bioresorbable materials and suitable for local drug delivery of antibiotics and immunomodulatory molecules.

Giuseppe obtained his M.S. Degree in Pharmaceutical Chemistry and Technology and his PhD in Biomolecular Pharmaceutical and Medical Sciences with Doctor Europaeus certification from the Department of Pharmacy – Pharmaceutical Sciences at the University of Bari. During his PhD, he spent six months in the laboratory of Prof. Fattal at the Institut Galien Paris-Sud. From 2022 to 2025, Dr. Racaniello held the position of RTD-A Researcher in Technology, Socioeconomics, and Drug Regulation at the Department of Pharmacy – Pharmaceutical Sciences, University of Bari. Giuseppe is currently a Post-doc at the at the Pharmaceutical Technology Lab, Department of Pharmacy – Pharmaceutical Sciences, University of Bari Aldo Moro, Italy. His research focuses on the design, development, and technological characterization of innovative pharmaceutical dosage forms produced via 3D printing technology, with a particular emphasis on the production of personalized solid and semi-solid formulations using material extrusion techniques.